A New Remote Monitoring System: Evaluation of the Efficiency and Accuracy of the SEMS-HIOT Device

SEMS-HIOT as New Remote Health Care Device


  • Mohammad Taghi Hedayati Goudarzi Cardiology Department, Rohani Hospital, School of Medicine, Babol University of Medical Sciences, Babol, Iran
  • Hadi Zaremarzouni Qaen Faculty of Medical Sciences, Birjand University of Medical Sciences, Birjand, Iran
  • Fazel Tarkhan Biomedical and Microbial Advanced Technologies (BMAT) Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  • Ali Bijani Department of Epidemiology, Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  • Mehdi Babagoli IT Engineering Group, Department of Industrial Engineering, K.N. Toosi University of Technology, Tehran, Iran
  • Amirhossein Shadifar Department of Electrical and Computer Engineering, Faculty of Electrical Engineering, Babol Noshirvani University of Technology, Babol, Iran
  • Javad Abbas Alipour Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran


Background: The remote medical monitoring system can facilitate monitoring patients with cardiac arrhythmia, and consequently, reduce mortality and complications in individuals requiring emergency interventions. Hence, it is necessary to evaluate new telemedicine devices and compare them with standard devices. Therefore, this study aimed to evaluate and compare the new remote monitoring system, Smart Emergency Medical System-Health Internet of Things (SEMS-HIOT) developed by the Health Technology Development Centre of Babol University of Medical Sciences on patients with different cardiac arrhythmias and compare it with the standard device. Materials and Methods: In this case-control study, 60 patients were divided into the six most common arrhythmia groups (n=10 per each group and equal gender) as atrial fibrillation, ventricular tachycardia, paroxysmal supraventricular tachycardia, premature ventricular contractions, atrial tachycardia, and premature atrial contractions. Also, 20 healthy individuals (including 10 men and 10 women) without any arrhythmia (normal rhythm) were considered as the control group. Three similar SEMS-HIOT devices were used as test devices and a standard cardiac monitoring device as the control device. The clinical parameters, including heart rate, pulse rate, oxygen saturation, body temperature, and cardiac electrical activity via electrocardiogram (ECG) lead-II were recorded. Results: Findings showed that the performance of the SEMS-HIOT test device was similar and in the same range for all indices in each group and there were no significant differences compared to the performance of the control device (P>0.05). Also, the ECG records measured with  SEMS-HIOT and standard device indicate no significant differences (P>0.05). Conclusion: Our study showed that the cardiac indices as well as ECG findings, which were measured with SEMS-HIOT and common standard devices confirmed the accuracy and reliability of the new telematics device for monitoring patients with cardiac diseases.






Original Article